Boothbay Fund Management’s Reviva Pharmaceuticals Warrants RVPHW Stock Holding History

Boothbay Fund Management’s Portfolio RVPHW Stock Details RVPHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-107,701	Closed	-$438K	–	2177
2021 Q3	$438K	Hold	107,701	–	–	0.01%	1148
2021 Q2	$523K	Sell	107,701 -14,459	-12%	-$6.51K	0.02%	981
2021 Q1	$701K	Sell	122,160 -77,840	-39%	-$50.2K	0.03%	768
2020 Q4	$1.75M	Hold	200,000	–	–	0.07%	307
2020 Q3	$2.15M	Sell	200,000 -60,086	-23%	-$26.8K	0.13%	206
2020 Q2	$2.8M	Hold	260,086	–	–	0.19%	137
2020 Q1	$2.74M	Buy	260,086 +65,021	+33%	+$9.73K	0.23%	108
2019 Q4	$2.04M	Hold	195,065	–	–	0.18%	154
2019 Q3	$2.02M	Hold	195,065	–	–	0.19%	139
2019 Q2	$2M	Hold	195,065	–	–	0.18%	138
2019 Q1	$1.96M	Buy	+195,065	New	+$38.6K	0.19%	127

Other funds holding RVPHW

BCM

BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

Boothbay Fund Management's RVPHW Position: Q4 2021 in Review

Boothbay Fund Management sold out of Reviva Pharmaceuticals Warrants (RVPHW) in Q4 2021, closing a stake of 107,701 shares — an estimated $438K sold.

Boothbay Fund Management first reported a position in RVPHW in Q1 2019 and held it in 11 quarters. The position peaked at $2.8M in Q2 2020. 6 funds tracked by Wall St. Rank hold RVPHW as of Q4 2021.

Boothbay Fund Management reported no remaining Reviva Pharmaceuticals Warrants position as of Q4 2021 after selling out during the quarter.
Boothbay Fund Management sold 107,701 Reviva Pharmaceuticals Warrants shares in Q4 2021, an estimated $438K.
Boothbay Fund Management first reported a position in Reviva Pharmaceuticals Warrants in Q1 2019 and held it in 11 quarters.
Boothbay Fund Management's Reviva Pharmaceuticals Warrants position peaked at $2.8M in Q2 2020.
6 funds tracked by Wall St. Rank held Reviva Pharmaceuticals Warrants as of Q4 2021.

Based on Boothbay Fund Management's 13F filing for Q4 2021, filed 14 Feb 2022.